281 related articles for article (PubMed ID: 16672363)
21. Involvement of the bone morphogenetic protein/receptor system during follicle development in the bovine ovary: Hormonal regulation of the expression of bone morphogenetic protein 7 (BMP-7) and its receptors (ActRII and ALK-2).
Shimizu T; Jayawardana BC; Nishimoto H; Kaneko E; Tetsuka M; Miyamoto A
Mol Cell Endocrinol; 2006 Apr; 249(1-2):78-83. PubMed ID: 16513253
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding.
Zhang JL; Qiu LY; Kotzsch A; Weidauer S; Patterson L; Hammerschmidt M; Sebald W; Mueller TD
Dev Cell; 2008 May; 14(5):739-50. PubMed ID: 18477456
[TBL] [Abstract][Full Text] [Related]
23. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.
Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T
Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215
[TBL] [Abstract][Full Text] [Related]
24. Binding of integrin α1 to bone morphogenetic protein receptor IA suggests a novel role of integrin α1β1 in bone morphogenetic protein 2 signalling.
Zu Y; Liang X; Du J; Zhou S; Yang C
J Biomech; 2015 Nov; 48(14):3950-4. PubMed ID: 26475222
[TBL] [Abstract][Full Text] [Related]
25. BMPR-II is dispensable for formation of the limb skeleton.
Gamer LW; Tsuji K; Cox K; Capelo LP; Lowery J; Beppu H; Rosen V
Genesis; 2011 Sep; 49(9):719-24. PubMed ID: 21538804
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
27. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.
Kirsch T; Nickel J; Sebald W
EMBO J; 2000 Jul; 19(13):3314-24. PubMed ID: 10880444
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions.
Singhatanadgit W; Salih V; Olsen I
J Cell Physiol; 2006 Dec; 209(3):912-22. PubMed ID: 17001689
[TBL] [Abstract][Full Text] [Related]
29. The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding.
Klages J; Kotzsch A; Coles M; Sebald W; Nickel J; Müller T; Kessler H
Biochemistry; 2008 Nov; 47(46):11930-9. PubMed ID: 18937504
[TBL] [Abstract][Full Text] [Related]
30. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
Groppe J; Hinck CS; Samavarchi-Tehrani P; Zubieta C; Schuermann JP; Taylor AB; Schwarz PM; Wrana JL; Hinck AP
Mol Cell; 2008 Feb; 29(2):157-68. PubMed ID: 18243111
[TBL] [Abstract][Full Text] [Related]
31. Site-directed mutagenesis of the type II TGF-beta receptor indicates a ligand-binding site distinct from that of the type II activin receptor.
Guimond A; Sulea T; Pen A; Ear P; O'Connor-McCourt MD
FEBS Lett; 2002 Mar; 515(1-3):13-9. PubMed ID: 11943186
[TBL] [Abstract][Full Text] [Related]
32. Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.
Heinecke K; Seher A; Schmitz W; Mueller TD; Sebald W; Nickel J
BMC Biol; 2009 Sep; 7():59. PubMed ID: 19735544
[TBL] [Abstract][Full Text] [Related]
33. A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors.
Greenwald J; Vega ME; Allendorph GP; Fischer WH; Vale W; Choe S
Mol Cell; 2004 Aug; 15(3):485-9. PubMed ID: 15304227
[TBL] [Abstract][Full Text] [Related]
34. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.
Ebisawa T; Tada K; Kitajima I; Tojo K; Sampath TK; Kawabata M; Miyazono K; Imamura T
J Cell Sci; 1999 Oct; 112 ( Pt 20)():3519-27. PubMed ID: 10504300
[TBL] [Abstract][Full Text] [Related]
35. High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry.
Khodr V; Machillot P; Migliorini E; Reiser JB; Picart C
Biointerphases; 2021 Jun; 16(3):031001. PubMed ID: 34241280
[TBL] [Abstract][Full Text] [Related]
36. A single residue of GDF-5 defines binding specificity to BMP receptor IB.
Nickel J; Kotzsch A; Sebald W; Mueller TD
J Mol Biol; 2005 Jun; 349(5):933-47. PubMed ID: 15890363
[TBL] [Abstract][Full Text] [Related]
37. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
Sebald W; Nickel J; Zhang JL; Mueller TD
Biol Chem; 2004 Aug; 385(8):697-710. PubMed ID: 15449706
[TBL] [Abstract][Full Text] [Related]
38. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.
Thompson TB; Woodruff TK; Jardetzky TS
EMBO J; 2003 Apr; 22(7):1555-66. PubMed ID: 12660162
[TBL] [Abstract][Full Text] [Related]
39. Molecular recognition of BMP-2 and BMP receptor IA.
Keller S; Nickel J; Zhang JL; Sebald W; Mueller TD
Nat Struct Mol Biol; 2004 May; 11(5):481-8. PubMed ID: 15064755
[TBL] [Abstract][Full Text] [Related]
40. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors.
Harrison CA; Gray PC; Fischer WH; Donaldson C; Choe S; Vale W
J Biol Chem; 2004 Jul; 279(27):28036-44. PubMed ID: 15123686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
